Clinical
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
VERONA: Katherine Talcott, MD, on early gains with a TKI insert in DME
3
City Therapeutics doses first participant in phase 1 trial of RNAi therapy CITY-RBP4 for Stargardt disease
4
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
5